Royalty Pharma
Price & Volume
Stats
See more52W Range | $33.56-$60.44 |
Market Cap | $32.8B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $2.5B |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | $2.4B |
Diluted EPS | $1.86 |
News
See moreYahoo Finance • 6 days ago
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance
Yahoo Finance • 6 days ago
Royalty Pharma Q2 26 Earnings Conference Call At 8:00 AM ET
Yahoo Finance • 6 days ago
Royalty Pharma reports second quarter 2026 results
Yahoo Finance • 20 days ago
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
About
CEO | Mr. Pablo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |